Skip to content

The Implementation of Computer-aided Detection in Training Improves the Quality of Future Colonoscopies

The Implementation of Computer-aided Detection in an Initial Endoscopy Training Improves the Quality Measures of Trainees' Future Colonoscopies

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06623331
Enrollment
6000
Registered
2024-10-02
Start date
2022-01-01
Completion date
2024-03-31
Last updated
2025-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Artificial Intelligence (AI), Colonoscopy Diagnostic Techniques and Procedures, Quality Indicators, Health Care

Keywords

Quality Indicators, Colonoscopy, Artificial Intelligence (AI), Computer-aided detection (CADe), Adenoma detection rate (ADR)

Brief summary

Computer-aided detection (CADe) based on artificial intelligence (AI) may improve colonoscopy quality. An increasing number of young endoscopists are trained in an AI environment. However its impact on trainees' future outcomes remains unclear. The study aimed to evaluate the quality indicators of endoscopists trained in an AI environment compared to those trained conventionally.

Detailed description

Computer-aided detection (CADe) based on artificial intelligence (AI) may improve colonoscopy quality. An increasing number of young endoscopists are trained in an AI environment. However its impact on trainees' future outcomes remains unclear. The study aimed to evaluate the quality indicators of endoscopists trained in an AI environment compared to those trained conventionally. A study included 6,000 adult patients who underwent a colonoscopy for various reasons. The study retrospectively evaluated the first 1,000 procedures performed by six endoscopists after completing training relying entirely on endoscopists' detection skills without AI enhancement. Three of those young endoscopists were trained with CADe, and three without additional assistance. Quality indicators were assessed in both groups. The morphology of detected polyps was evaluated to determine the influence of AI-enhanced training on laterally spreading tumors (LST) detection rate.

Interventions

OTHERAI-enhanced endoscopy training

Endoscopists trained in AI-enhanced environment. Their quality indicators are measured after completing training, without additional AI enhancement.

OTHERConventional endoscopy training

Endoscopists trained conventionally

Sponsors

Jagiellonian University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adult participants who underwent a colonoscopy for various reasons performed by specific endoscopists that were assessed in terms of quality indicators

Exclusion criteria

* a history of bowel resection * confirmed inflammatory bowel disease * suspicion of polyps or cancer in other imaging tests * suspicion of familial adenomatous polyposis

Design outcomes

Primary

MeasureTime frameDescription
Cecal intubation rate (CIR)During the colonoscopy examinationThe percentage of colonoscopies with successful cecal intubations
Serrated polyp detection rate (SDR)During the colonoscopy examinationThe percentage of colonoscopies when the serrated polyp was found
withdrawal timeDuring the colonoscopy examinationThe time from the cecal intubation to the end of the examination
Adenoma per colonoscopy score (APC)During the colonoscopy examinationThe average number of adenomas detected in a single colonoscopy
Adenoma Detection Rate (ADR)During the colonoscopy examinationThe percentage of colonoscopies when the adenoma was found
Advanced adenoma detection rate (AADR)During the colonoscopy examinationThe percentage of colonoscopies when the advanced adenoma (>10mm) was found

Secondary

MeasureTime frameDescription
Laterally spreading tumor detection rateDuring the colonoscopy examinationThe percentage of colonoscopies when the laterally spreading tumor lesion was found

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026